Fresenius Medical Care (NYSE:FMS; ETR:FRE) said last Thursday that Standard & Poor’s upgraded its corporate credit rating to BBB.
The Bad Homburg, Germany-based company said that S&P gave them a BBB rating with a stable outlook from BBB- with a positive outlook.
Fresenius said that it is rated as investment grade by the three leading rating agencies Standard & Poor’s, Moody’s and Fitch, according to an SEC filing.
Earlier this month, Fresenius saw shares rise slightly after the dialysis-focused device maker beat expectations on Wall Street with its first quarter earnings release.
Building Better Companies at DeviceTalks Minnesota
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%! REGISTER NOW |
MassDevice Network
@MassDevice
LinkedIn
YouTube
Leave a Reply
You must be logged in to post a comment.